Mechanisms and clinical significance of antifungal resistance

被引：3

作者：

Bille, J ^{[1
]}

机构：

[1] CHU Vaudois, Clin Microbiol Lab, CH-1011 Lausanne, Switzerland

来源：

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2000年 / 16卷 / 03期

关键词：

polyene resistance; 5-FC resistance; azole resistance;

D O I：

10.1016/S0924-8579(00)00260-0

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

[No abstract available]

引用

页码：331 / 333

页数：3

共 12 条

[1] Correlation between in vitro susceptibility determined by E test and response to therapy with amphotericin B: Results from a multicenter prospective study of candidemia [J].

Clancy, CJ ;

Nguyen, MH .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (05) :1289-1290

[2]

MARCHETTI O, 1998, 15006 ICAAC

[3] Rapid, transient fluconazole resistance in Candida albicans is associated with increased mRNA levels of CDR [J].

Marr, KA ;

Lyons, CN ;

Rustad, T ;

Bowden, RA ;

White, TC .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (10) :2584-2589

[4] Declining rates of oropharyngeal candidiasis and carriage of Candida albicans associated with trends toward reduced rates of carriage of fluconazole-resistant C-albicans in human immunodeficiency virus-infected patients [J].

Martins, MD ;

Lozano-Chiu, M ;

Rex, JH .

CLINICAL INFECTIOUS DISEASES, 1998, 27 (05) :1291-1294

[5]

*NCCLS, 1997, M27A NCCLS, V17

[6]

Nguyen MH, 1996, AM J MED, V100, P617, DOI 10.1016/S0002-9343(95)00010-0

[7] A RANDOMIZED TRIAL COMPARING FLUCONAZOLE WITH AMPHOTERICIN-B FOR THE TREATMENT OF CANDIDEMIA IN PATIENTS WITHOUT NEUTROPENIA [J].

REX, JH ;

BENNETT, JE ;

SUGAR, AM ;

PAPPAS, PG ;

VANDERHORST, CM ;

EDWARDS, JE ;

WASHBURN, RG ;

SCHELD, WM ;

KARCHMER, AW ;

DINE, AP ;

LEVENSTEIN, MJ ;

WEBB, CD .

NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (20) :1325-1330

[8] Diethylcarbamazine-related antimicrobial activity in Mycobacterium tuberculosis-infected blood [J].

Kitchen, LW ;

Weston, CM ;

Day, SP .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (02) :241-243

[9] MECHANISMS OF RESISTANCE TO AZOLE ANTIFUNGAL AGENTS IN CANDIDA-ALBICANS ISOLATES FROM AIDS PATIENTS INVOLVE SPECIFIC MULTIDRUG TRANSPORTERS [J].

SANGLARD, D ;

KUCHLER, K ;

ISCHER, F ;

PAGANI, JL ;

MONOD, M ;

BILLE, J .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (11) :2378-2386

[10] Multiple resistance mechanisms to azole antifungals in yeast clinical isolates [J].

Sanglard, D ;

Ischer, F ;

Calabrese, D ;

de Micheli, M ;

Bille, J .

DRUG RESISTANCE UPDATES, 1998, 1 (04) :255-265

← 1 2 →